m*********3
发帖数: 1425 | 1 Pharmaceutical giant GlaxoSmithKline is laying off another 180 workers at
its Research Triangle Park Campus.
The job cuts, which are in addition to a previously announced round of
layoffs, were disclosed Monday in a letter to the state Department of
Commerce. Employees affected by the latest layoffs already have been
notified, said spokeswoman Mary Anne Rhyne.
The new layoffs impact GSK’s commercial business and include sales,
managerial, marketing and support staff jobs.
In December GSK announced that it was eliminating about 900 research-and-
development jobs in RTP throughout 2015. However, about half of those
employees were offered jobs at Parexel, a contract research organization
that helps drug companies conduct clinical trials of experimental drugs and
analyze the results.
The employees who shifted to Parexel are still working at GSK’s campus.
Parexel has leased one of the drug company’s buildings, Rhyne said.
Both rounds of layoffs are part of a $1.6 billion, three-year cost-cutting
effort that GSK announced in October.
GSK didn’t disclose the commercial job cuts when it announced the R&D
reductions because, at that time, it hadn’t determined how many commercial
workers would be affected, Rhyne said.
Prior to the initiation of the layoffs, London-based GSK employed about 5,
000 workers in the Triangle – 4,500 at its North American headquarters in
RTP and 500 at its manufacturing plant in Zebulon.
GSK’s sales fell 5 percent overall in the fourth quarter, with U.S. sales
declining 10 percent. Intense global competition and cheaper generic drugs
are among the forces hurting GSK and other drugmakers.
Read more here: http://www.newsobserver.com/news/business/article16123580.html#storylink=cpy |
|
